Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:52:20.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:54:00.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates an accessibility issue rather than a substantive content update, leaving the page in an error state.
    Difference
    17%
    Check dated 2026-09-21T22:13:22.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now shown, replacing v3.6.5. This indicates an internal page or template update rather than any changes to the study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-08-31T17:20:32.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, signaling a minor deployment update to the page. This update does not alter the study details or other content.
    Difference
    0.1%
    Check dated 2026-08-10T07:32:10.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.3 to v3.6.4, indicating a new build/maintenance update of the ClinicalTrials.gov page. This update does not alter the study content or data displayed.
    Difference
    0.1%
    Check dated 2026-07-26T18:57:38.000Z thumbnail image

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.